Autoimmune hemolytic anemia diagnostic study of choice: Difference between revisions
Created page with "__NOTOC__ {{Autoimmune hemolytic anemia}} {{CMG}} ==Overview== ==Diagnotic study of choice for autoimmune hemolytic anemia== ==Refrences== {{Reflist|2}}" |
|||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Diagnosis of autoimmune hemolytic anemia is based on laboratory results. The best way to make a diagnosis is to start with a less costly [[CBC]] followed by confirmatory [[coombs test]] to define type of autoimmune hemolysis. | |||
==Diagnotic study of choice for autoimmune hemolytic anemia== | ==Diagnotic study of choice for autoimmune hemolytic anemia== | ||
* Diagnosis of autoimmune hemolytic anemia is based on laboratory results. <ref name="pmid22400097">{{cite journal| author=Biswas S. Chandrashekhar P. Varghese M| title=Coomb's Positive Hemolytic Anemia Due To Insect Bite. | journal=Oman Med J | year= 2007 | volume= 22 | issue= 3 | pages= 62-3 | pmid=22400097 | doi= | pmc=3294156 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22400097 }} </ref> | |||
* The best way to make a diagnosis is to start with a less costly CBC followed by confirmatory [[coombs test]] to define type of autoimmune hemolysis. | |||
* By definition, autoimmune hemolytic anemia is characterized by anemia.<ref name="pmid25705656">{{cite journal| author=Berentsen S, Sundic T| title=Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. | journal=Biomed Res Int | year= 2015 | volume= 2015 | issue= | pages= 363278 | pmid=25705656 | doi=10.1155/2015/363278 | pmc=4326213 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25705656 }} </ref> | |||
* Seeing [[schistocytes]] in [[peripheral blood smear]] is a sensitive but non-specific test for diagnosis of autoimmune hemolytic anemia. | |||
* Coombs test can narrow down our diagnosis in autoimmune hemolytic anemia. | |||
==Refrences== | ==Refrences== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 10:56, 20 September 2018
Autoimmune hemolytic anemia Microchapters |
Differentiating Autoimmune hemolytic anemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Autoimmune hemolytic anemia diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Autoimmune hemolytic anemia diagnostic study of choice |
FDA on Autoimmune hemolytic anemia diagnostic study of choice |
CDC on Autoimmune hemolytic anemia diagnostic study of choice |
Autoimmune hemolytic anemia diagnostic study of choice in the news |
Blogs on Autoimmune hemolytic anemia diagnostic study of choice |
Directions to Hospitals Treating Autoimmune hemolytic anemia |
Risk calculators and risk factors for Autoimmune hemolytic anemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Diagnosis of autoimmune hemolytic anemia is based on laboratory results. The best way to make a diagnosis is to start with a less costly CBC followed by confirmatory coombs test to define type of autoimmune hemolysis.
Diagnotic study of choice for autoimmune hemolytic anemia
- Diagnosis of autoimmune hemolytic anemia is based on laboratory results. [1]
- The best way to make a diagnosis is to start with a less costly CBC followed by confirmatory coombs test to define type of autoimmune hemolysis.
- By definition, autoimmune hemolytic anemia is characterized by anemia.[2]
- Seeing schistocytes in peripheral blood smear is a sensitive but non-specific test for diagnosis of autoimmune hemolytic anemia.
- Coombs test can narrow down our diagnosis in autoimmune hemolytic anemia.
Refrences
- ↑ Biswas S. Chandrashekhar P. Varghese M (2007). "Coomb's Positive Hemolytic Anemia Due To Insect Bite". Oman Med J. 22 (3): 62–3. PMC 3294156. PMID 22400097.
- ↑ Berentsen S, Sundic T (2015). "Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy". Biomed Res Int. 2015: 363278. doi:10.1155/2015/363278. PMC 4326213. PMID 25705656.